These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9557019)

  • 1. ['Labor storm' following cervical ripening with prostaglandin gel].
    van Gestel I; Roumen FJ
    Ned Tijdschr Geneeskd; 1998 Jan; 142(4):161-4. PubMed ID: 9557019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Uterine hyperstimulation following cervix ripening with dinoprostone in a vaginal insert system].
    Brouwers JM; Briët JW; Brouwers JR
    Ned Tijdschr Geneeskd; 2004 Jun; 148(26):1300-3. PubMed ID: 15279216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abruptio placentae associated with misoprostol use in women with preeclampsia.
    Fontenot MT; Lewis DF; Barton CB; Jones EM; Moore JA; Evans AT
    J Reprod Med; 2005 Sep; 50(9):653-8. PubMed ID: 16363752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaphylactoid syndrome of pregnancy after intracervical dinoprostone for cervical ripening: a report of 3 cases.
    Cusick W; Leuci D; Viscarello RR; Rodis JF
    J Reprod Med; 2005 Mar; 50(3):225-8. PubMed ID: 15841940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiotocographic abnormalities associated with dinoprostone and misoprostol cervical ripening.
    Ramsey PS; Meyer L; Walkes BA; Harris D; Ogburn PL; Heise RH; Ramin KD
    Obstet Gynecol; 2005 Jan; 105(1):85-90. PubMed ID: 15625147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of six hourly vaginal misoprostol versus intracervical dinoprostone: a randomized controlled trial.
    Denguezli W; Trimech A; Haddad A; Hajjaji A; Saidani Z; Faleh R; Sakouhi M
    Arch Gynecol Obstet; 2007 Aug; 276(2):119-24. PubMed ID: 17219155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dinoprostone: slow release vaginal insert (Propess) and intracervical gel (Prepidil) for the induction of labour with unriped cervix].
    Grignaffini A; Soncini E; Anfuso S; Ronzoni E
    Minerva Ginecol; 2004 Oct; 56(5):413-8. PubMed ID: 15531859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outpatient misoprostol compared with dinoprostone gel for preinduction cervical ripening: a randomized controlled trial.
    Meyer M; Pflum J; Howard D
    Obstet Gynecol; 2005 Mar; 105(3):466-72. PubMed ID: 15738009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of misoprostol for cervical ripening.
    Katz VL; Farmer RM; Dean CA; Carpenter ME
    South Med J; 2000 Sep; 93(9):881-4. PubMed ID: 11005347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological induction of labour: benefits and risks].
    Romanelli M; Ribiani E; Burnelli L; Luzi G; Affronti G; Di Renzo GC
    Minerva Ginecol; 2007 Aug; 59(4):347-55. PubMed ID: 17923826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of prostaglandin E2 in cervix maturation and labor induction. Clinical experience].
    Rech F; Patella A; Cecchi A; Indraccolo SR
    Minerva Ginecol; 1995 Oct; 47(10):423-9. PubMed ID: 8559432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inducing labor with intracervical prostaglandin (PG) gel administration. A comparative analysis of 171 patients with 2 different preparations of PGE2 with regard to course of labor and fetal outcome].
    Wallwiener D; Aydeniz B; Grischke EM; Abbasi I; Bastert G
    Z Geburtshilfe Neonatol; 1998; 202(4):149-53. PubMed ID: 9783372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of misoprostol or prostaglandin E(2) for induction of labor on the incidence of pathological CTG tracing: a randomized trial.
    Megalo A; Petignat P; Hohlfeld P
    Eur J Obstet Gynecol Reprod Biol; 2004 Sep; 116(1):34-8. PubMed ID: 15294364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparing two Prepidil gel regimens for cervical ripening before induction of labor at term: a randomized trial].
    Fekih M; Ben Zina N; Jnifen A; Nouri S; Ben Regaya L; Memmi A; Bouguizene S; Chaieb A; Bibi M; Sboui H; Khairi H
    J Gynecol Obstet Biol Reprod (Paris); 2009 Jun; 38(4):335-40. PubMed ID: 19467806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of prostaglandin E2 tablets or Foley catheter for labour induction in grand multiparas.
    Al-Taani MI
    East Mediterr Health J; 2004; 10(4-5):547-53. PubMed ID: 16335645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine rupture and labor induction with prostaglandins.
    Phuapradit W; Herabutya Y; Saropala N
    J Med Assoc Thai; 1993 May; 76(5):292-5. PubMed ID: 8006562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of uterine hyperstimulation after prostaglandin E2 administration.
    Goyert GL; Mariona FG
    Obstet Gynecol; 1987 Sep; 70(3 Pt 2):468-70. PubMed ID: 3476877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy and safety of vaginal misoprostol versus dinoprostone vaginal insert in labor induction at term: a randomized trial.
    Ozkan S; Calişkan E; Doğer E; Yücesoy I; Ozeren S; Vural B
    Arch Gynecol Obstet; 2009 Jul; 280(1):19-24. PubMed ID: 19034471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mode of delivery in pregnancies with premature rupture of membranes at or before term following induction of labor with vaginal prostaglandin E2.
    Ben-Haroush A; Yogev Y; Glickman H; Bar J; Kaplan B; Hod M
    Am J Perinatol; 2004 Jul; 21(5):263-8. PubMed ID: 15232758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two preparations of dinoprostone for pre-induction of labour in nulliparous women with very unfavourable cervical condition: a randomised clinical trial.
    Facchinetti F; Venturini P; Verocchi G; Volpe A
    Eur J Obstet Gynecol Reprod Biol; 2005 Apr; 119(2):189-93. PubMed ID: 15808378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.